FDA approves Lilly diabetes drug that analysts expect to be a big seller
The Food and Drug Administration said Friday it had approved Mounjaro, a new injection for type 2 diabetes made by Eli Lilly that lowers blood sugar and can help patients lose weight.
The agency emphasized in a press release that in clinical trials Mounjaro was more effective than other treatments that were studied.
Read Original Article: FDA approves Lilly diabetes drug that analysts expect to be a big seller »
